Trademark: 90701065
Word
MAKE CANCER A BENIGN EXPERIENCE
Status
Registered
Status Code
700
Status Date
Tuesday, January 23, 2024
Serial Number
90701065
Registration Number
7287794
Registration Date
Tuesday, January 23, 2024
Mark Type
4000
Filing Date
Monday, May 10, 2021
Published for Opposition
Tuesday, June 14, 2022

Trademark Owner History
Earli Inc. - Original Registrant

Classifications
5 Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
44 Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer

Trademark Events
Jan 23, 2024
Notice Of Registration Confirmation Emailed
Jan 23, 2024
Registered-Principal Register
Dec 19, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 18, 2023
Allowed Principal Register - Sou Accepted
Dec 7, 2023
Teas/Email Correspondence Entered
Dec 7, 2023
Correspondence Received In Law Office
Dec 7, 2023
Assigned To Lie
Jul 7, 2023
Teas Response To Office Action Received
Apr 10, 2023
Notification Of Non-Final Action E-Mailed
Apr 10, 2023
Non-Final Action E-Mailed
Apr 10, 2023
Su - Non-Final Action - Written
Feb 24, 2023
Statement Of Use Processing Complete
Feb 1, 2023
Use Amendment Filed
Feb 23, 2023
Case Assigned To Intent To Use Paralegal
Feb 1, 2023
Teas Statement Of Use Received
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2022
Published For Opposition
May 25, 2022
Notification Of Notice Of Publication E-Mailed
May 10, 2022
Approved For Pub - Principal Register
May 10, 2022
Examiner's Amendment Entered
May 10, 2022
Notification Of Examiners Amendment E-Mailed
May 10, 2022
Examiners Amendment E-Mailed
May 10, 2022
Examiners Amendment -Written
May 7, 2022
Teas/Email Correspondence Entered
May 6, 2022
Correspondence Received In Law Office
May 6, 2022
Teas Response To Office Action Received
Feb 23, 2022
Notification Of Non-Final Action E-Mailed
Feb 23, 2022
Non-Final Action E-Mailed
Feb 23, 2022
Non-Final Action Written
Jan 20, 2022
Teas/Email Correspondence Entered
Jan 20, 2022
Correspondence Received In Law Office
Jan 20, 2022
Teas Response To Office Action Received
Jan 13, 2022
Notification Of Non-Final Action E-Mailed
Jan 13, 2022
Non-Final Action E-Mailed
Jan 13, 2022
Non-Final Action Written
Jan 13, 2022
Assigned To Examiner
Aug 10, 2021
New Application Office Supplied Data Entered
May 13, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24